TMBR Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases

$0.12  +0.00 (3.13%)
As of 09/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/04/2015
Outstanding shares:  132,451,180
Average volume:  11,248,730
Market cap:   $14,821,287
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.25
PB ratio:   1.40
PS ratio:   15.28
Return on equity:   -113.37%
Net income %:   -1,234.21%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy